1. FRI0382 Impact of Treatments on Major Immunologic Pathways in SLE Depends on Type I Interferon Signature: Analysis from Biomarkers of Lupus Disease (BOLD) Study. (10th June 2014) Authors: Merrill, J.T.; Immermann, F.W.; Zhou, T.; O'Toole, M.; Whitley, M.; Hill, A.A.; Zhang, Y.; von Schack, D.; Reddy, P.S.; Masferrer, J.L.; Kamp, S.; Guthridge, J.M.; Thanou, A.; Wu, P.; Paradis, T.; Mounts, W.M.; James, J.A.; Sridharan, S.T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗